Skip to main content
Funded Studies

Lisa Claire McConlogue, PhD

Professor at The University of California, San Francisco

Location: San Francisco, CA United States

Dr. Lisa McConlogue is a visiting investigator at the Gladstone Institutes and Professor of Biochemistry and Biophysics at The University of California, San Francisco, where she leads translational efforts targeting alpha-synuclein, a key target for Parkinson's disease. Prior to her transition to academia, Dr. McConlogue led discovery efforts in the biopharmaceutical industry, most recently as a distinguished research fellow at Elan Pharmaceuticals. She made pioneering discoveries in neurodegenerative diseases, including establishing the first Alzheimer's pre-clinical model and identifying and validating therapeutic targets including beta-secretase (BACE), the rate-limiting enzyme in the production Abeta, a central player in Alzheimer's disease. Dr. McConlogue established the key role of BACE in plaque and synaptic pathology and demonstrated a pathogenic role for soluble Abeta assemblies. She went on to lead the Elan Parkinson's disease discovery efforts, including alpha-synuclein antibody vaccine-based approaches and the development of pharmacological chaperones for alpha-synuclein. At UCSF, she leads mechanistic and translational efforts targeting alpha-synuclein.

Associated Grants

  • Small-Molecule Pharmacological Chaperones Reverse Alpha-synuclein-impaired Debris Removal


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.